Tu Youyou was born in 1930 in the city of Ningbo on the east coast of China. Her family stressed education for her and her four brothers, but she had to take a two-year break from studying at 16 because she had contracted tuberculosis. When she returned to school, she knew exactly what she wanted to study: medicine. She wanted to find cures for diseases like the one that had afflicted her. At Beijing Medical College, Tu studied pharmacology, learning how to classify medicinal plants, extract active ingredients and determine their chemical structures. When she graduated in 1955 at the age of 24, Tu was assigned to work at the newly established Academy of Traditional Chinese Medicine, where she would stay for her entire career. From 1959 to 1962, she took a full-time course in traditional Chinese medicine for researchers trained in modern Western methods. North Vietnam asked China for help with battling malaria, which was causing tremendous casualties among its soldiers in the Vietnam War. The single-celled parasite that causes malaria had become resistant to chloroquine, the standard malaria treatment. Chairman Mao Zedong launched Project 523 on 23 May 1967 to find a cure for chloroquine-resistant malaria. In 1969, when she was 39 years old, Tu was appointed head of Project 523. Her first order of business was researching the effects of malaria in Situ. And for that, she traveled to Hainan Island in southern China, which was currently experiencing a malaria outbreak of its own. In those rainforests, Tu witnessed first-hand the disease’s devastating toll on the human body. She had to leave her one-year-old daughter with her parents and put her four-year-old in a nursery. “The work was the top priority so I was certainly willing to sacrifice my personal life,” Tu later said. It would be three years before she saw her children again. Upon their return to Beijing, the team reviewed ancient medical texts to understand traditional Chinese ways of fighting malaria. At that point over 240,000 compounds had already been tested for use in potential antimalarial drugs, and none had worked. Finally, the team found a reference to sweet wormwood, which had been used in China around 400 AD to treat “intermittent fevers,” a symptom of malaria. In 1971, Tu’s team isolated one active compound in wormwood that seemed to battle malaria-friendly parasites. They tested extracts of the compound but nothing worked. So Tu returned once more to the ancient text. She wondered whether the active ingredient in wormwood was being damaged when they boiled the wormwood to prepare the solvent, and so she tried another preparation, this time with an ether-based solvent. Since it boils at a lower temperature, the wormwood wasn’t damaged; when she tested it on mice and monkeys, it had a 100 percent success rate. Tu and two colleagues tested the substance on themselves before testing them on 21 patients in the Hainan Province. All of them recovered. The following year, Tu's team distilled the compound’s active ingredient, artemisinin, and shared their findings. While her work was not published in English until 1979, shortly after in 1981, the WHO, World Bank, and UN each invited her to present her findings on the global stage. It took two decades, but finally the WHO recommended artemisinin combination therapy as the first line of defense against malaria. The Lasker Foundation, which awarded Tu its Clinical Medical Research Award in 2011, called the discovery of artemisinin “arguably the most important pharmaceutical intervention in the last half-century.” She also earned the 2015 Nobel Prize for Physiology and Medicine - the first mainland Chinese scientist to achieve this feat. Source:https://www.nobelprize.org/womenwhochangedscience/stories/tu-youyou

click here